ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,603 | +206.3% | 3,610 | -21.7% | 0.00% | +100.0% |
| Q2 2023 | $1,503 | -42.5% | 4,610 | -24.1% | 0.00% | 0.0% |
| Q1 2023 | $2,612 | -18.9% | 6,075 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $3,220 | -19.5% | 6,075 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $4,000 | -42.9% | 6,075 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $7,000 | -41.7% | 6,075 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $12,000 | -29.4% | 6,075 | 0.0% | 0.01% | -25.0% |
| Q4 2021 | $17,000 | +1600.0% | 6,075 | +5422.7% | 0.01% | +700.0% |
| Q3 2021 | $1,000 | 0.0% | 110 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,000 | – | 110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 507,191 | $5,107,000 | 0.50% |
| Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
| Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
| NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
| EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
| AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
| FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
| Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
| Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
| DEUTSCHE BANK AG\ | 859 | $8,000 | 0.00% |